Nipt Test: A Complete Medical Overview

The nipt test is a noninvasive prenatal blood screening that looks at small fragments of placental DNA in the pregnant person’s blood to estimate the chance of certain chromosome conditions. It can be highly informative, but it is a screening test rather than a diagnosis, so abnormal results usually need confirmation with further testing.

Overview: what the NIPT test is

The nipt test, also called noninvasive prenatal testing or cell-free DNA screening, is a blood test used during pregnancy to assess the chance that the fetus has certain chromosome conditions. It analyzes tiny fragments of DNA that come mainly from the placenta and circulate in the pregnant person’s bloodstream. Because it only requires a blood sample, it does not involve entering the uterus and does not carry the miscarriage risk associated with invasive diagnostic procedures.

This test is most commonly used to screen for trisomy 21 (Down syndrome), trisomy 18, and trisomy 13. Some versions also assess sex chromosome differences and may report fetal sex. In selected situations, some laboratories offer expanded screening for certain microdeletions or additional chromosome changes, although these expanded panels may be less well validated and are not appropriate for everyone.

A useful way to understand NIPT is to think of it as a probability tool. It can estimate whether the pregnancy is at higher or lower risk for a specific chromosome condition, but it cannot by itself prove that the fetus has or does not have that condition. For that reason, NIPT is usually considered alongside medical history, ultrasound findings, and, when needed, diagnostic tests.

Who may consider NIPT and when it is done

NIPT is commonly discussed as part of routine prenatal care for many pregnant patients, regardless of age. It may be especially considered when there is a higher chance of chromosome differences, such as advanced maternal age, certain ultrasound findings, a prior pregnancy with a chromosome condition, or a positive result from another prenatal screening test. However, its use has expanded because it can provide helpful information even in pregnancies without known risk factors.

In many settings, the test can be performed from around 10 weeks of pregnancy onward. Timing can vary slightly depending on the laboratory, the type of pregnancy, and the amount of placental DNA in the bloodstream, sometimes called the fetal fraction. If the fetal fraction is too low, the laboratory may not be able to issue a result, and repeat testing or other evaluation may be recommended.

NIPT can also be used in some twin pregnancies, though interpretation may be more complex than in a singleton pregnancy. In pregnancies involving an egg donor, surrogacy, or assisted reproductive techniques such as IVF, the test may still be possible, but the doctor may explain important limitations before ordering it.

What conditions the test can screen for

The core purpose of the nipt test is to screen for common chromosome conditions caused by an extra or missing chromosome. The most established use is for trisomy 21, which is linked to Down syndrome. Many tests also screen for trisomy 18 and trisomy 13, which are less common but can cause serious medical and developmental problems.

Some test panels assess sex chromosome differences involving the X or Y chromosome, such as Turner syndrome or Klinefelter syndrome. These findings can be more difficult to interpret than screening for trisomy 21, and a positive result may not always reflect the fetus. In some cases, the result may be related to placental changes or, more rarely, factors affecting the pregnant person.

Expanded NIPT panels may include selected microdeletions or rare autosomal abnormalities. These are not offered in the same way everywhere, and their accuracy may be lower than for the more common trisomies. A doctor or genetic counselor can help explain whether broader screening is likely to be useful in a specific pregnancy.

• Most established screening targets: trisomy 21, trisomy 18, and trisomy 13
• Possible additional targets: sex chromosome differences
• Sometimes offered: selected microdeletions or rare chromosome changes
• Not designed to detect all genetic conditions, birth defects, or pregnancy complications

How the test is performed and what can affect accuracy

The procedure itself is straightforward. A healthcare professional takes a blood sample from the pregnant person, and the sample is sent to a laboratory that analyzes cell-free DNA. Results are usually reported as low risk, high risk, or occasionally inconclusive. Some laboratories use slightly different wording, so it is helpful to review the exact report with a clinician.

NIPT is generally very good at screening for trisomy 21, but no screening test is perfect. False-positive and false-negative results can occur. Test performance can vary depending on the condition being screened for, the laboratory method, whether the pregnancy is singleton or twin, and the fetal fraction in the blood sample.

Several factors can affect interpretation. These include a low fetal fraction, maternal weight, early gestational age, a vanished twin, placental mosaicism, or rare maternal chromosome differences. Because the DNA analyzed comes mainly from the placenta rather than directly from the fetus, the test may occasionally reflect placental findings that are not present in the fetus itself.

Ultrasound remains an important part of prenatal care because NIPT does not evaluate fetal anatomy. A normal NIPT result does not replace the need for routine scans, including detailed imaging when recommended. If a scan shows structural differences, the care team may discuss further evaluation, including amniocentesis or other diagnostic tests.

Understanding NIPT results

A low-risk result means the test found a lower chance of the specific chromosome conditions included in that panel. This can be reassuring, but it does not guarantee that the fetus does not have a genetic condition, a birth defect, or a health problem not covered by the test. It also does not completely eliminate the possibility of the screened conditions.

A high-risk result means there is an increased chance of a specific chromosome condition. It is not the same as a diagnosis. The next step is usually a detailed discussion with an obstetrician, maternal-fetal medicine specialist, or genetic counselor, along with an ultrasound review and consideration of confirmatory testing.

Sometimes the result is inconclusive or reported as “no call.” This may happen if there is not enough placental DNA in the blood sample or if the analysis is technically limited. In that situation, repeating the test may be possible, but the doctor may instead recommend ultrasound review or diagnostic testing depending on the pregnancy and the reason for the inconclusive result.

Confirmatory diagnostic testing may include chorionic villus sampling in early pregnancy or amniocentesis later in pregnancy. These tests study fetal or placental cells directly and can provide a more definite answer. Decision-making can feel complex, so many patients benefit from careful counseling before and after testing.

Benefits, limitations, and emotional considerations

One of the main benefits of the nipt test is that it offers screening information early in pregnancy without an invasive procedure. This can help patients and families prepare emotionally, gather information, plan follow-up care, or consider diagnostic testing if needed. For many people, the test provides reassurance when results are low risk.

Its main limitation is that it is not comprehensive and not diagnostic. It does not screen for every chromosome condition, most single-gene disorders, many inherited conditions, or all fetal structural differences. It also does not replace standard prenatal evaluations such as ultrasound, routine blood work, and regular obstetric appointments.

Another practical limitation is that results can raise questions rather than settle them completely. A high-risk or inconclusive report can create uncertainty and anxiety while further testing is arranged. Clear communication is important, and patients should feel comfortable asking what exactly was screened, how reliable the result is for that finding, and what the next steps are.

Some patients also want to think in advance about how much information they would like to receive, including whether they want fetal sex information or screening for less common findings. A discussion before testing can help align the test choice with personal values, medical history, and the goals of prenatal care.

What happens after the test and when to seek medical care

After the blood sample is taken, the care team reviews the report in the context of the pregnancy as a whole. If the result is low risk, routine prenatal care usually continues, including recommended ultrasounds and checkups. If the result is high risk or inconclusive, the clinician may advise a detailed ultrasound, referral to a maternal-fetal medicine specialist, genetic counseling, or diagnostic testing to clarify the finding.

Medical attention should be sought promptly if there are urgent pregnancy symptoms, whether or not NIPT has been done. These include vaginal bleeding, severe abdominal pain, fever, fluid leakage, fainting, severe headache, vision changes, or reduced fetal movement later in pregnancy. NIPT is a screening tool and is not designed to evaluate urgent symptoms.

It is also sensible to contact a doctor if a patient does not understand the result, receives a no-call report, or learns of an abnormal ultrasound finding despite a low-risk NIPT. These situations do not always mean there is a serious problem, but they do deserve timely medical review. In some cases, clinicians may discuss broader prenatal assessment, including genetic consultation and imaging, or referral related to high-risk pregnancy care.

For international patients who need coordinated prenatal evaluation, Acibadem International’s multidisciplinary specialists in JCI-accredited hospitals assess screening results, provide counseling, and arrange further testing or pregnancy care when appropriate.

Frequently asked questions

Is the NIPT test the same as a diagnostic genetic test?

No. The NIPT test is a screening test that estimates the chance of certain chromosome conditions, but it cannot confirm or exclude them with complete certainty. If the result is high risk, doctors usually recommend confirmatory diagnostic testing such as chorionic villus sampling or amniocentesis.

How early in pregnancy can NIPT be done?

In many cases, NIPT can be performed from around 10 weeks of pregnancy. The exact timing may depend on the laboratory, the pregnancy type, and whether there is enough placental DNA in the blood sample to analyze.

What does a low-risk NIPT result mean?

A low-risk result means the test found a lower chance of the chromosome conditions included in that screening panel. It is reassuring, but it does not guarantee that the fetus has no genetic condition or structural abnormality, and routine prenatal care should still continue.

Can NIPT be wrong?

Yes. Although NIPT is highly accurate for some conditions, especially trisomy 21, false-positive and false-negative results can still occur. Accuracy can also vary depending on the condition screened, fetal fraction, and clinical factors such as twin pregnancy or placental mosaicism.

Why would an NIPT result come back inconclusive?

An inconclusive or no-call result often happens when there is too little placental DNA in the blood sample for reliable analysis. It can also occur for technical reasons or because of specific pregnancy factors, and the next step may be repeat testing, ultrasound review, or diagnostic testing.

Does a normal NIPT result mean ultrasound is no longer needed?

No. Ultrasound and routine prenatal visits remain essential because NIPT does not assess fetal anatomy or many non-chromosomal conditions. A pregnancy can have a normal NIPT result and still need further evaluation if ultrasound findings are abnormal.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.